Boston Children’s Hospital ends bad blood between donors, patients.
In 2013, anemia, a condition in which one does not have enough healthy red blood cells,
Tag: Immucor
PreciseType on air in Boston
Local hospital using new technology to match blood donors, recipients Children’s Hospital in Boston is among the first hospitals in the nation to use new technology that better matches blood donors with blood recipients. View the segment here.
PreciseType in NJBiz
Warren firm’s new blood-typing test relies on genetic analysis for more specific results By Beth Fitzgerald A new test that uses genetic analysis to more accurately determine a person’s blood type has been developed by a New Jersey biotechnology company that is now ramping up commercial production and marketing of its novel PreciseType test to […]
PreciseType in WSJ
Hospitals Aim to Better Match Blood Donors and Recipients New Risks to Patients Needing Transfusions As researchers uncover more genetic variations in blood types, they are identifying new risks to patients needing transfusions. Read the article here.
PreciseType in San Diego Union-Tribune
Read the full article about new medical devices here.
Immucor's PreciseType lauded by The Scientist
Read the The Scientist’s Top 10 Innovations here.
FDA panel recommends OK for Immucor test
The U.S. Food and Drug Administration’s (FDA) Blood Products Advisory Committee voted to recommend approval of Immucor Inc.’s HEA Molecular BeadChip Test as a safe and effective evaluation for blood group typing. The test provides additional information about the composition of donor and patient blood, which may result in better matches for blood transfusion patients, […]